Abstract
Peroxisome proliferator-activated receptor γ (PPARγ) is a metabolic regulator involved in maintaining glucose and fatty acid homeostasis. Besides its metabolic functions, the receptor has also been implicated in tumorigenesis. Ligands of PPARγ induce apoptosis in several types of tumor cells, leading to the proposal that these ligands may be used as antineoplastic agents. However, apoptosis induction requires high doses of ligands, suggesting the effect may not be receptor-dependent. In this report, we show that PPARγ is expressed in human primary T-cell lymphoma tissues and activation of PPARγ with low doses of ligands protects lymphoma cells from serum starvation-induced apoptosis. The prosurvival effect of PPARγ was linked to its actions on cellular metabolic activities. In serum-deprived cells, PPARγ attenuated the decline in ATP, reduced mitochondrial hyperpolarization, and limited the amount of reactive oxygen species (ROS) in favor of cell survival. Moreover, PPARγ regulated ROS through coordinated transcriptional control of a set of proteins and enzymes involved in ROS metabolism. Our study identified cell survival promotion as a novel activity of PPARγ. These findings highlight the need for further investigation into the role of PPARγ in cancer before widespread use of its agonists as anticancer therapeutics.
Original language | English |
---|---|
Pages (from-to) | 722-732 |
Number of pages | 11 |
Journal | American Journal of Pathology |
Volume | 170 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2007 |
Keywords
- Adenosine Triphosphate/metabolism
- Antineoplastic Agents/pharmacology
- Apoptosis/drug effects
- Cell Line, Tumor
- Cell Survival/drug effects
- Dose-Response Relationship, Drug
- Fatty Acids/metabolism
- Glucose/metabolism
- Humans
- Hypoglycemic Agents/pharmacology
- Ligands
- Lymphoma, T-Cell/drug therapy
- Membrane Potential, Mitochondrial/drug effects
- Mitochondria/metabolism
- Neoplasm Proteins/agonists
- PPAR gamma/agonists
- Peroxisome Proliferators/pharmacology
- Prostaglandin D2/analogs & derivatives
- Pyrimidines/pharmacology
- Reactive Oxygen Species/metabolism
- Rosiglitazone
- Thiazolidinediones/pharmacology